Improvement of the HIV fusion inhibitor C34 activity by membrane anchoring and enhanced exposure

被引:0
|
作者
Augusto, M. T. [1 ]
Hollmann, A. [1 ]
Castanho, M. A. R. B. [1 ]
Pessi, A. [2 ]
Santos, N. C. [1 ]
机构
[1] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal
[2] PeptiPharma, Rome, Italy
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S165 / S165
页数:1
相关论文
共 50 条
  • [1] Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure
    Augusto, Marcelo T.
    Hollmann, Axel
    Castanho, Miguel A. R. B.
    Porotto, Matteo
    Pessi, Antonello
    Santos, Nuno C.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (05) : 1286 - 1297
  • [2] Enhanced HIV fusion inhibitors efficacy requires membrane affinity and exposure of the PBD of C34
    Augusto, M. T.
    Hollmann, A.
    Castanho, M. A. R. B.
    Porotto, M.
    Pessi, A.
    Santos, N. C.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2015, 44 : S233 - S233
  • [3] Enhanced HIV Fusion Inhibitors Efficacy Requires Membrane Affinity and Exposure of the Pocket Binding Domain of C34 Derivatives
    Augusto, Marcelo T.
    Hollmann, Axel
    Castanho, Miguel A. R. B.
    Porotto, Matteo
    Pessi, Antonello
    Santos, Nuno C.
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 555A - 555A
  • [4] C34, a membrane fusion inhibitor, blocks HIV infection of Langerhans cells and viral transmission to T cells
    Sugaya, Makoto
    Hartley, Oliver
    Root, Michael J.
    Blauvelt, Andrew
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (06) : 1436 - 1443
  • [5] Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Synergistically Potentiates Peptide-Membrane Interaction
    Matos, Pedro M.
    Hollmann, Axel
    Castanho, Miguel A.
    Santos, Nuno C.
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 490A - 490A
  • [6] Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-Membrane Interactions Potentiating Its Action
    Hollmann, Axel
    Matos, Pedro M.
    Augusto, Marcelo T.
    Castanho, Miguel A. R. B.
    Santos, Nuno C.
    PLOS ONE, 2013, 8 (04):
  • [7] Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-membrane linteractions Potentiating its Action
    Hollmann, Axel
    Matos, Pedro M.
    Augusto, Marcelo T.
    Castanho, Miguel A. R. B.
    Santos, Nuno C.
    BIOPOLYMERS, 2013, 100 (03) : 299 - 299
  • [8] Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor EQUIPOTENT TO C34 AND T-20 IN VITRO WITH SUSTAINED ACTIVITY IN SCID-HU THY/LIV MICE
    Stoddart, Cheryl A.
    Nault, Genevieve
    Galkina, Sofiya A.
    Thibaudeau, Karen
    Bakis, Peter
    Bousquet-Gagnon, Nathalie
    Robitaille, Martin
    Bellomo, Maryanne
    Paradis, Veronique
    Liscourt, Patricia
    Lobach, Alexandra
    Rivard, Marie-Eve
    Ptak, Roger G.
    Mankowski, Marie K.
    Bridon, Dominique
    Quraishi, Omar
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (49) : 34045 - 34052
  • [9] C34, a membrane fusion inhibitor, blocks HIV infection of human Langerhans cells (LC) and LC-mediated transfer of virus to T cells
    Sugaya, M
    Root, M
    Blauvelt, A
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A125 - A125
  • [10] Dimeric C34 Derivatives Linked through Disulfide Bridges as New HIV-1 Fusion Inhibitors
    Kobayakawa, Takuya
    Ebihara, Kento
    Honda, Yuzuna
    Fujino, Masayuki
    Nomura, Wataru
    Yamamoto, Naoki
    Murakami, Tsutomu
    Tamamura, Hirokazu
    CHEMBIOCHEM, 2019, 20 (16) : 2101 - 2108